Highlights of the 2009 Scientific Sessions of the Heart Failure Society of America, Boston, MA, September 13-16, 2009
To access this article, please choose from the options below
Dr. O'Connor has received research funding from NHLBI, Merck, Medtronic, Johnson and Johnson and Bioheart. Dr. Mann has received research funding from the NIH and serves as a consultant for Acorn Cardiovascular, ARMGO Pharma, Cardiokine, Circulate, Medtronic, Miragen, Mile Pharmaceuticals and Novartis.
PII: S1071-9164(09)01174-9
doi:10.1016/j.cardfail.2009.11.001
© 2010 Published by Elsevier Inc.
